4
MARKET OVERVIEW
Highlights the market structure, growth drivers, restraints, and near-term inflection points influencing performance.
4.3
UNMET NEEDS AND WHITE SPACES
4.4
INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
5
INDUSTRY TRENDS
Maps the market evolution with focus on trend catalysts, risk factors, and growth opportunities across segments.
5.1
PORTER’S FIVE FORCES ANALYSIS
5.2
MACROECONOMICS INDICATORS
5.2.2
GDP TRENDS AND FORECAST
5.2.3
TRENDS IN HEALTHCARE IT INDUSTRY
5.5.1
INDICATIVE PRICE FOR EUROPE NUCLEAR MEDICINE, BY KEY PLAYERS (2024)
5.6
KEY CONFERENCES AND EVENTS, 2026–2027
5.7
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.8
INVESTMENT AND FUNDING SCENARIO
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
6.1
KEY EMERGING TECHNOLOGIES
6.2
COMPLEMENTARY TECHNOLOGIES
6.3
TECHNOLOGY/PRODUCT ROADMAP
6.6
IMPACT OF AI/GEN AI ON EUROPE NUCLEAR MEDICINE
6.6.1
TOP USE CASES AND MARKET POTENTIAL
6.6.2
BEST PRACTICES IN EUROPE NUCLEAR MEDICINE MARKET
6.6.3
CASE STUDIES OF AI IMPLEMENTATION IN THE EUROPE NUCLEAR MEDICINE MARKET
6.6.4
INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
6.6.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN THE MARKET
7.1
REGIONAL REGULATIONS AND COMPLIANCE
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
8.1
DECISION-MAKING PROCESS
8.2
BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
9
EUROPE NUCLEAR MEDICINE MARKET, BY TYPE (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
9.2
DIAGNOSTIC NUCLEAR MEDICINE
9.2.1
SPECT RADIOISOTOPES
9.2.1.5
OTHER SPECT ISOTOPES
9.2.2.3
OTHER PET ISOTOPES
9.3
THERAPEUTIC NUCLEAR MEDICINE
9.3.2.6
OTHER BETA EMITTERS
9.3.3
BRACHYTHERAPY ISOTOPE
9.3.3.5
OTHER BRACHYTHERAPY ISOTOPES
10
EUROPE NUCLEAR MEDICINE MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
10.2
DIAGNOSTIC APPLICATIONS
10.2.1
SPECT APPLICATIONS
10.2.1.5
OTHER SPECT APPLICATIONS
10.2.2.4
OTHER PET APPLICATIONS
10.3
THERAPEUTIC APPLICATIONS
10.3.1
THYROID INDICATIONS
10.3.5
OTHER THERAPEUTIC APPLICATIONS
11
EUROPE NUCLEAR MEDICINE MARKET, BY VOLUME ASSESSMENT (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
11.2
DIAGNOSTIC PROCEDURES
11.3
THERAPEUTIC PROCEDURES
12
EUROPE NUCLEAR MEDICINE MARKET, BY END USER (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
12.4
ACADEMIC & RESEARCH CENTERS
13
EUROPE NUCLEAR MEDICINE MARKET, BY COUNTRY (MARKET SIZE & FORECAST TO 2030)
Market Size, Volume & Forecast – USD Million
STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL
14.2
KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN
14.3
REVENUE ANALYSIS (2020-2024)
14.4
MARKET SHARE ANALYSIS (2024)
14.5
BRAND/SOFTWARE COMPARATIVE ANALYSIS
14.6
COMPANY EVALUATION MATRIX: KEY PLAYERS,
14.6.5
COMPANY FOOTPRINT: KEY PLAYERS,
14.6.5.1
COMPANY FOOTPRINT
14.6.5.2
REGION FOOTPRINT
14.6.5.4
APPLICATION FOOTPRINT
14.6.5.5
VOLUME ASSESSMENT FOOTPRINT
14.6.5.6
END USER FOOTPRINT
14.7
COMPANY EVAULATION MATRIX: STARTUPS/SMES,
14.7.1
PROGRESSIVE COMPANIES
14.7.3
RESPONSIVE COMPANIES
14.7.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES,
14.7.5.1
DETAILED LIST OF KEY STARTUPS/SMES
14.7.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
14.8
COMPANY VALUATION AND FINANCIAL METRICS
14.9
COMPETITIVE SCENARIOS
14.9.1
PRODUCT LAUNCHES & UPGRADES
IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, SERVICES, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE MARKET LANDSCAPE
15.1.1.1
BUSINESS OVERVIEW
15.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
15.1.1.3.1
KEY STRENGTHS/RIGHT TO WIN
15.1.1.3.2
STRATEGIC CHOICES
15.1.1.3.3
WEAKNESS/COMPETITIVE THREATS
15.1.5
LANTHEUS HOLDINGS, INC.
15.1.7
JUBILANT PHARMOVA LIMITED
15.1.8
BRACCO IMAGING S.P.A
15.1.9
PHARMALOGIC HOLDINGS CORP.
15.1.10
SUN PHARMACEUTICAL INDUSTRIES, INC.
15.1.12
SIEMENS HEALTHINEEERS AG
15.1.13
NORTHSTAR MEDICAL RADIOISOTOPES, LLC
15.1.16
SHINE TECHNOLOGIES, LLC
15.1.17
TELIX PHARMACEUTICALS LIMITED.
15.1.18
PDRADIOPHARMA INC.
15.1.19
ITM ISOTOPE TECHNOLOGIES MUNICH SE
15.1.20
BWX TECHNOLOGIES INC.
15.2.2
INSTITUTE OF ISOTOPES
16.1.1.1
KEY DATA FROM SECONDARY SOURCES
16.1.2.1
KEY DATA FROM PRIMARY SOURCES
16.1.2.2
KEY PRIMARY PARTICIPANTS
16.1.2.3
BREAKDOWN OF PRIMARY INTERVIEWS
16.1.2.4
KEY INDUSTRY INSIGHTS
16.2
MARKET SIZE ESTIMATION
16.2.1
BOTTOM-UP APPROACH
16.2.3
BASE NUMBER CALCULATION
16.3
MARKET FORECAST APPROACH
16.6
RESEARCH ASSUMPTIONS
16.7
RESEARCH LIMITATIONS AND RISK ASSESSMENT
17.2
KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
17.3
CUSTOMIZATION OPTIONS
Growth opportunities and latent adjacency in Europe Nuclear Medicine Market